Capsida Biotherapeutics
Founded
2019
2019
Clinical Trials
1
1
Technologies
VirotherapyCapsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ.
adeno-associated virus genetic disorders gene therapy
